Dr. Izar is a medical oncologist and the Vivian and Seymour Milstein Family Assistant Professor of Medicine at Columbia University. His lab studies the intersection of cancer immunology, tumor genomics, and metastatic organotropism. These factors dictate clinical drug responses/resistance to existing and investigational targeted and immune-based therapies; his laboratory has published several landmark studies in this field. Dr. Izar has an active clinical practice focusing on treating patients with melanoma, and, as member of the early drug development program, other solid tumors. He is the PI on immunotherapy trials in this space and holds several patents pertaining to the development of novel cancer therapies.